to 15 March 2019
at CSIR-Indian Institute of Chemical Biology, Jadavpur Campus
DATE |
TIME |
VENUE |
SPEAKER |
AFFILIATION |
TITLE |
11th March, Monday |
11:30 – 1:00 PM |
2nd Floor Seminar Room/ Auditorium |
Dr. Eva Gluenz |
Royal Society University Research Fellow, Sir William Dunn School of Pathology, University of Oxford, UK. |
How to edit Leishmania genes with the LeishGEdit toolkit: a practical introduction Discovery of Leishmania motility mutants in a CRISPR-Cas9 knockout screen |
12th March, Tuesday |
9:00 – 10:00 AM |
2nd Floor Seminar Room/ Auditorium |
Dr. Jeremy Mottram |
Chair in Pathogen Biology Centre for Immunology and Infection, University of York, Heslington, York |
Using CRISPR for drug target validation in Leishmania |
10:00 –11:00 AM |
Dr. Ana Paula Lima |
Universidade Federal de Uberlândia (UFU), Área de Periodontia e Implantodontia (FOUFU), Uberlândia, Brazil |
Virulence factors in viscerotropic Leishmania |
||
11:30 – 12: 30 PM |
Dr. Benu Brata Das |
Assistant Professor & Wellcome-Trust/ India Alliance Fellow, Indian Association for the Cultivation of Science, Kolkata, West Bengal |
Genomic instability from DNA-protein crosslinks: Unraveling novel DNA repair pathways in the protozoan parasites |
||
13th March, Wednesday |
9:00 – 10:00 AM |
2nd Floor Seminar Room/ Auditorium |
Dr. Tony Wilkinson |
Department of Chemistry, University of York |
Protein Lipidation as a Drug Target in Parasitic Diseases |
10:00 – 11:00 AM |
Dr. Nathaniel Jones |
Loyola University Medical Center, USA |
Bromodomain proteins as drug targets in Leishmania |
||
11:30 – 12:30PM |
Dr. Hemanta Kumar Majumdar |
Senior Scientist NASI, Rajaramanna Fellow, Sir J.C. Bose National Fellow, Indian Institute of chemical Biology. |
Deleting DNA repair genes from Leishmania: Therapeutic implication |
||
14th March, Thursday |
9:00 – 10.00 AM |
2nd Floor Seminar Room/ Auditorium |
Dr. Sudipta Das |
Ramalingaswami Fellow, CSIR-Indian Institute Of Chemical Biology |
Na+ and cholesterol homeostasis in Plasmodium falciparum : Targets of novel anti-malarials |
10:00 – 11:00 AM |
Dr. Nahid Ali |
J. C. Bose Fellow, CSIR-Indian Institute Of Chemical Biology |
Multiple interventions in the management of visceral leishmaniasis and the prospects of CRISPR |
||
11:30 – 12: 30PM |
Dr. Amitava Sengupta |
Senior Scientist, CSIR-Indian Institute Of Chemical Biology |
CRISPR/Cas guided gene editing in HSCs |
||
15th March, Friday |
9:00 – 10.00 AM |
2nd Floor Seminar Room/ Auditorium |
Dr. Richard McCulloch |
Reader (Parasitology), Associate (School of Life Sciences) Institute of Infection, Immunity & Inflammation, University of Glasgow |
DNA recombination in trypanosomatids; relevance to CRISPR editing |
10:00 – 11:00 AM |
Dr. R. V. Shaji |
Professor, Christian Medical College, Vellore |
Gene editing in iPSCs for disease modeling |
||
11:30 – 12: 30PM |
Dr. Debojyoti Chakraborty |
Senior Scientist, CSIR-Institute of Genomics and Integrative Biology |
CRISPR V2.0 : tackling specificity for gene therapy applications |